These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 10331044)
21. Study of the cyclosporine concentration at 2 hours in stable renal transplant patients and relation to body mass index. Hortal L; Fernández A; Losada A; Lorenzo M; Baamonde E; Plaza C; Gallego R; Vega N; Palop L Transplant Proc; 2001; 33(7-8):3110-1. PubMed ID: 11750337 [No Abstract] [Full Text] [Related]
29. Conversion from Sandimmune to Neoral in renal transplant recipients: two-year experience. Wilczek HE; Akesson P; Warholm C Transplant Proc; 1998 Aug; 30(5):1753-5. PubMed ID: 9723267 [No Abstract] [Full Text] [Related]
30. High QT dispersion in tacrolimus-treated kidney transplant recipients. Gerhardt U; Suwelack B; Pawolka A; Hohage H Transplant Proc; 2001 May; 33(3):2148-50. PubMed ID: 11377482 [No Abstract] [Full Text] [Related]
31. Cyclosporine trough levels in diabetic and nondiabetic renal transplant patients. Wadhawan S; Jauhari H; Singh S Transplant Proc; 2000 Nov; 32(7):1683-4. PubMed ID: 11119891 [No Abstract] [Full Text] [Related]
32. Experience with clinical use of Sandimmun Neoral in renal transplant patients. Min ZL; Zhao M; Zhu YH; Qi J; Wang LM; Wang YW Transplant Proc; 1996 Jun; 28(3):1356-7. PubMed ID: 8658692 [No Abstract] [Full Text] [Related]
33. Pharmacokinetic study of twice vs thrice daily dosing of Sandimmun Neoral in pediatric renal transplant patients. Papachristou F; Gakis D; Sotiriou I; Liatsis I; Takoudas D; Antoniadis A Transplant Proc; 1998 Aug; 30(5):1988-90. PubMed ID: 9723363 [No Abstract] [Full Text] [Related]
34. Decreased nephrotoxicity after the use of a microemulsion formulation of cyclosporine A compared to conventional solution. Ahlmén J; Sundberg A; Gustavsson A; Strömbom U Transplant Proc; 1995 Dec; 27(6):3432-3. PubMed ID: 8540036 [No Abstract] [Full Text] [Related]
35. Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients--a comment. Zehngawa W Eur J Clin Pharmacol; 2005 Jun; 61(4):317. PubMed ID: 15891875 [No Abstract] [Full Text] [Related]
36. Interactions of cyclosporin A and amlodipine: blood cyclosporin A levels, hypertension and kidney function. Schrama YC; Koomans HA J Hypertens Suppl; 1998 Sep; 16(4):S33-8. PubMed ID: 9817190 [TBL] [Abstract][Full Text] [Related]
37. Optimization of cyclosporine therapy with abbreviated area under the curve method in renal transplant. Yang WC; Chen YF; King KL; Wu TH; Chen Hsu RY ; Tang JJ; Loong CC; Chou MH; Lin MF; Lui WY Transplant Proc; 2000 Nov; 32(7):1685-7. PubMed ID: 11119892 [No Abstract] [Full Text] [Related]
38. The effect of cyclosporin A on the level of big endothelin in patients one year after orthotopic heart transplantation. Kocík M; Málek I; Glagolicová A; Pirk J Transpl Int; 2004 Feb; 17(2):65-70. PubMed ID: 14634722 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and renal function after conversion from standard to microemulsion formulation of cyclosporine in stable renal transplant patients. Gaspari F; Anedda MF; Signorini O; Amuchastegui SC; Perico N; Remuzzi G Transplant Proc; 1998 Aug; 30(5):1654-5. PubMed ID: 9723229 [No Abstract] [Full Text] [Related]
40. Ten years after: long-term effects of cyclosporine-based immunosuppression on renal allograft recipients. Kondo T; Kinukawa T; Takeuchi N; Hattori R; Ono Y; Matsuura O; Fujita T; Ohshima S Transplant Proc; 1998 Nov; 30(7):3530-2. PubMed ID: 9838546 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]